-
1
-
-
0032561972
-
Treatment of myocardial infarction
-
Gershlik AH, More RS. Treatment of myocardial infarction. Br Med J 1998; 316:280-4.
-
(1998)
Br Med J
, vol.316
, pp. 280-284
-
-
Gershlik, A.H.1
More, R.S.2
-
2
-
-
0031577151
-
Clinical epidemiology of coronary heart disease in the UK
-
Gandhi MM. Clinical epidemiology of coronary heart disease in the UK. Br J Hosp Med 1997;58:23-7.
-
(1997)
Br J Hosp Med
, vol.58
, pp. 23-27
-
-
Gandhi, M.M.1
-
3
-
-
0018932163
-
Prevalence of total coronary artery occlusion during the early hours of transmural myocardial infarction
-
DeWood MA, Spores J, Notske R, Mouser LT, et al. Prevalence of total coronary artery occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
-
(1980)
N Engl J Med
, vol.303
, pp. 897-902
-
-
DeWood, M.A.1
Spores, J.2
Notske, R.3
Mouser, L.T.4
-
4
-
-
0001288621
-
The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy
-
Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians 1958;71:287-96.
-
(1958)
Trans Assoc Am Physicians
, vol.71
, pp. 287-296
-
-
Fletcher, A.P.1
Alkjaersig, N.2
Smyrniotis, F.E.3
Sherry, S.4
-
5
-
-
0022640774
-
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
-
Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i: 397-402.
-
(1986)
Lancet
, vol.1
, pp. 397-402
-
-
-
6
-
-
0023805341
-
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
-
ISIS-2 (Second International Study of Infarct Survival) Collaborators Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;ii:349-60.
-
(1988)
Lancet
, vol.2
, pp. 349-360
-
-
-
7
-
-
0032574630
-
Thrombolysis for acute myocardial infarction
-
White HD, Van de Werf FJJ. Thrombolysis for acute myocardial infarction. Circulation 1998;97:1632-46.
-
(1998)
Circulation
, vol.97
, pp. 1632-1646
-
-
White, H.D.1
Van De Werf, F.J.J.2
-
8
-
-
0027240597
-
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
-
The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-82.
-
(1993)
N Engl J Med
, vol.329
, pp. 673-682
-
-
-
9
-
-
0028914981
-
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: Importance of early and complete infarct artery reperfusion
-
Simes RJ, Topol EJ, Holmes DRJ, White HD, et al, for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation 1995;91:1923-8.
-
(1995)
Circulation
, vol.91
, pp. 1923-1928
-
-
Simes, R.J.1
Topol, E.J.2
Holmes, D.R.J.3
White, H.D.4
-
10
-
-
0021916187
-
Thrombolysis in Myocardial Infarction (TIMI) trial: Phase 1 findings
-
TIMI Study Group. Thrombolysis in Myocardial Infarction (TIMI) trial: phase 1 findings. N Engl J Med 1985;312:932-6.
-
(1985)
N Engl J Med
, vol.312
, pp. 932-936
-
-
-
11
-
-
0027424433
-
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
-
The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
-
(1993)
N Engl J Med
, vol.329
, pp. 1615-1622
-
-
-
12
-
-
0028039957
-
Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
-
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
-
(1994)
Lancet
, vol.343
, pp. 311-322
-
-
-
13
-
-
0030596903
-
Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
-
Boersma E, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
-
(1996)
Lancet
, vol.348
, pp. 771-775
-
-
Boersma, E.1
Maas, A.C.P.2
Deckers, J.W.3
Simoons, M.L.4
-
14
-
-
0026764571
-
Time delays in provision of thrombolytic treatment in six district hospitals
-
Birkhead JS, on behalf of the Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of the Royal College of Physicians of London. Time delays in provision of thrombolytic treatment in six district hospitals. Br Med J 1992;305:445-8.
-
(1992)
Br Med J
, vol.305
, pp. 445-448
-
-
Birkhead, J.S.1
-
15
-
-
0020033705
-
Early reporting of myocardial infarction; impact of an experiment on patient education
-
Rowley JM, Hill JD, Hampton JR, Mitchel JRA. Early reporting of myocardial infarction; impact of an experiment on patient education. Br Med J 1982;284:1741-6.
-
(1982)
Br Med J
, vol.284
, pp. 1741-1746
-
-
Rowley, J.M.1
Hill, J.D.2
Hampton, J.R.3
Mitchel, J.R.A.4
-
16
-
-
0026752147
-
Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction
-
Boutten MJM, Simoons ML, Hartman JAM, van Miltenberg AJM, et al. Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction. Eur Heart J 1992;13:925-31.
-
(1992)
Eur Heart J
, vol.13
, pp. 925-931
-
-
Boutten, M.J.M.1
Simoons, M.L.2
Hartman, J.A.M.3
Van Miltenberg, A.J.M.4
-
17
-
-
0026698925
-
Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners; Grampian region early anistreplase trial
-
Great Group. Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners; Grampian region early anistreplase trial. Br Med J 1992; 305:548-53.
-
(1992)
Br Med J
, vol.305
, pp. 548-553
-
-
-
18
-
-
0003047223
-
Meta-analysis of randomised trials of prehospital versus hospital thrombolysis
-
abstract
-
Fath-Ordoubadi F, Al-Mohammad A, Huehns TY, Beatt KJ. Meta-analysis of randomised trials of prehospital versus hospital thrombolysis. Circulation 1994; 90:1-325 (abstract).
-
(1994)
Circulation
, vol.90
, pp. 1-325
-
-
Fath-Ordoubadi, F.1
Al-Mohammad, A.2
Huehns, T.Y.3
Beatt, K.J.4
-
19
-
-
0029899396
-
Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction
-
French JK, Williams BF, Hart HH, Wyatt S, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Br Med J 1996;312:1637-41.
-
(1996)
Br Med J
, vol.312
, pp. 1637-1641
-
-
French, J.K.1
Williams, B.F.2
Hart, H.H.3
Wyatt, S.4
-
20
-
-
20244376615
-
Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction
-
The MITI Project Group
-
Weaver WD, Litwin PE, Martin JS, Kudenchuk PJ, et al. The MITI Project Group. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol 1991;18:657-62.
-
(1991)
J Am Coll Cardiol
, vol.18
, pp. 657-662
-
-
Weaver, W.D.1
Litwin, P.E.2
Martin, J.S.3
Kudenchuk, P.J.4
-
21
-
-
0028918696
-
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients
-
Lee KL, Woodlief LH, Topol EJ, Weaver WD, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
-
(1995)
Circulation
, vol.91
, pp. 1659-1668
-
-
Lee, K.L.1
Woodlief, L.H.2
Topol, E.J.3
Weaver, W.D.4
-
22
-
-
10244242679
-
Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-I trial
-
White HD, Barbash GI, Califf RM, Simes RJ, et al, for the GUSTO-I Investigators. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial. Circulation 1996;94: 1826-33.
-
(1996)
Circulation
, vol.94
, pp. 1826-1833
-
-
White, H.D.1
Barbash, G.I.2
Califf, R.M.3
Simes, R.J.4
-
23
-
-
0031541276
-
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: Review of ocular haemorrhage incidence and location in the GUSTO-I trial
-
Mahaffey KW, Granger CB, Toth CA, White HD, et al, for the GUSTO-I Investigators. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular haemorrhage incidence and location in the GUSTO-I trial. ; J Am Coll Cardiol 1997;30:1606-10.
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 1606-1610
-
-
Mahaffey, K.W.1
Granger, C.B.2
Toth, C.A.3
White, H.D.4
-
24
-
-
0027494770
-
Patients with suspected myocardial infarction who present with ST depression
-
Lee HS, Cross SJ, Rawles J, Jennings K. Patients with suspected myocardial infarction who present with ST depression. Lancet 1993;342:1204-7.
-
(1993)
Lancet
, vol.342
, pp. 1204-1207
-
-
Lee, H.S.1
Cross, S.J.2
Rawles, J.3
Jennings, K.4
-
25
-
-
0030918917
-
Should patients with suspected acute myocardial infarction without ST elevation be given thrombolytic treatment?
-
Rawles J. Should patients with suspected acute myocardial infarction without ST elevation be given thrombolytic treatment? Eur Heart J 1997;18:899-906.
-
(1997)
Eur Heart J
, vol.18
, pp. 899-906
-
-
Rawles, J.1
-
26
-
-
0029923513
-
Late Assessment of Thrombolytic Efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction
-
Langer A, Goodman SG, Topol EJ, Charlesworth A, et al. Late Assessment of Thrombolytic Efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. J Am Coll Cardiol 1996;27:1327-32.
-
(1996)
J Am Coll Cardiol
, vol.27
, pp. 1327-1332
-
-
Langer, A.1
Goodman, S.G.2
Topol, E.J.3
Charlesworth, A.4
-
27
-
-
0031914990
-
Toward a new frontier in myocardial reperfusion therapy: Emerging platelet prominence
-
Topol EJ. Toward a new frontier in myocardial reperfusion therapy: emerging platelet prominence. Circulation 1998;97:211-8.
-
(1998)
Circulation
, vol.97
, pp. 211-218
-
-
Topol, E.J.1
-
29
-
-
2642654221
-
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
-
The PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498-505.
-
(1998)
N Engl J Med
, vol.338
, pp. 1498-1505
-
-
-
30
-
-
2642599026
-
Inhibition of the platelet glycoprotein iib/iiia receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
-
The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338: 1488-97.
-
(1998)
N Engl J Med
, vol.338
, pp. 1488-1497
-
-
-
31
-
-
0032560628
-
The PARAGON Investigators, international, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina
-
The PARAGON Investigators, international, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation 1998;97:2386-95.
-
(1998)
Circulation
, vol.97
, pp. 2386-2395
-
-
-
32
-
-
0008926519
-
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
-
The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-43.
-
(1998)
N Engl J Med
, vol.339
, pp. 436-443
-
-
-
33
-
-
0343849937
-
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction
-
Bode C, Smalling RW, Berg G, Burnett C, et al. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. Circulation 1996;94:891-8.
-
(1996)
Circulation
, vol.94
, pp. 891-898
-
-
Bode, C.1
Smalling, R.W.2
Berg, G.3
Burnett, C.4
-
34
-
-
0029142436
-
Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): Trial to investigate equivalence
-
International Joint Efficacy Comparison of Thrombolytics. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995;346:329-36.
-
(1995)
Lancet
, vol.346
, pp. 329-336
-
-
-
35
-
-
0030879325
-
A comparison of reteplase with alteplase for acute myocardial infarction
-
The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997;337: 1118-23.
-
(1997)
N Engl J Med
, vol.337
, pp. 1118-1123
-
-
-
36
-
-
0031456844
-
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
-
Weaver WD, Simes RJ, Ellis SG, Grines CL, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278:2093-8.
-
(1997)
JAMA
, vol.278
, pp. 2093-2098
-
-
Weaver, W.D.1
Simes, R.J.2
Ellis, S.G.3
Grines, C.L.4
-
37
-
-
0009522584
-
A randomized, placebo-controlled trial of abciximab with primary angioplasty for acute MI: The RAPPORT trial
-
abstract
-
Brener SJ, Barr LA, Burchenal J, Katz S, et al. A randomized, placebo-controlled trial of abciximab with primary angioplasty for acute MI: the RAPPORT trial. Circulation 1997;96(Suppl I):I-473 (abstract).
-
(1997)
Circulation
, vol.96
, Issue.SUPPL. I
-
-
Brener, S.J.1
Barr, L.A.2
Burchenal, J.3
Katz, S.4
-
38
-
-
0032581036
-
Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
-
Suryapranata H, van't Hof AWJ, Hoorntje JCA, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502-5.
-
(1998)
Circulation
, vol.97
, pp. 2502-2505
-
-
Suryapranata, H.1
Van't Hof, A.W.J.2
Hoorntje, J.C.A.3
De Boer, M.J.4
Zijlstra, F.5
-
39
-
-
0030937976
-
Analysis of the relative costs and effectiveness of primary angio-plasty versus tissue-type plasminogen activator: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial
-
Stone GW, Grines CL, Rothbaum D, Brown KF, et al. Analysis of the relative costs and effectiveness of primary angio-plasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) Trial. J Am Coll Cardiol 1997;29:901-7.
-
(1997)
J Am Coll Cardiol
, vol.29
, pp. 901-907
-
-
Stone, G.W.1
Grines, C.L.2
Rothbaum, D.3
Brown, K.F.4
-
40
-
-
0025335032
-
GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction
-
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
-
(1990)
Lancet
, vol.336
, pp. 65-71
-
-
-
41
-
-
0026607185
-
ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
-
ISIS-3 (Third International Study of Infarct Survival) Collaborators Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
-
(1992)
Lancet
, vol.339
, pp. 753-770
-
-
-
42
-
-
0026537021
-
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: Results of a randomised double blind European Cooperative Study Group trial
-
de Bono DP, Simoons ML, Tijssen J, Arnold AE, et al. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. Br Heart J 1992;67:122-8.
-
(1992)
Br Heart J
, vol.67
, pp. 122-128
-
-
De Bono, D.P.1
Simoons, M.L.2
Tijssen, J.3
Arnold, A.E.4
-
43
-
-
4243304248
-
Time dependent effect of treatment with ASA during thrombolytic therapy in acute myocardial infarction
-
abstract
-
Freimark D, Behar S, Matetsky S, Feinberg M, Hod H. Time dependent effect of treatment with ASA during thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol 1998;31:231 A (abstract).
-
(1998)
J Am Coll Cardiol
, vol.31
-
-
Freimark, D.1
Behar, S.2
Matetsky, S.3
Feinberg, M.4
Hod, H.5
-
45
-
-
0028641402
-
What happened to intravenous atenolol in acute myocardial infarction?
-
Sleight P. What happened to intravenous atenolol in acute myocardial infarction? Cardiology 1994;85:13-7.
-
(1994)
Cardiology
, vol.85
, pp. 13-17
-
-
Sleight, P.1
-
46
-
-
84888827980
-
Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-I
-
ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 1986;ii:57-66.
-
(1986)
Lancet
, vol.2
, pp. 57-66
-
-
-
47
-
-
0027491257
-
Effect of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: An overview of results from randomized controlled trials
-
Teo KK, Yusuf S, Furberg CD. Effect of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993;270: 1589-95.
-
(1993)
JAMA
, vol.270
, pp. 1589-1595
-
-
Teo, K.K.1
Yusuf, S.2
Furberg, C.D.3
-
48
-
-
0019459311
-
Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
-
The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
-
(1981)
N Engl J Med
, vol.304
, pp. 801-807
-
-
-
49
-
-
0020078179
-
A randomized trial of propranolol in patients with acute myocardial infarction
-
Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-14.
-
(1982)
JAMA
, vol.247
, pp. 1707-1714
-
-
-
50
-
-
0032552240
-
Effect of beta-blockade on mortality among high risk and low-risk patients after myocardial infarction
-
Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.
-
(1998)
N Engl J Med
, vol.339
, pp. 489-497
-
-
Gottlieb, S.S.1
McCarter, R.J.2
Vogel, R.A.3
-
51
-
-
0028932732
-
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
-
ISIS-4 (Fourth International Study of lnfarct Survival) Collaborative Croup. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-85.
-
(1995)
Lancet
, vol.345
, pp. 669-685
-
-
-
52
-
-
0028273258
-
GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
-
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
-
(1994)
Lancet
, vol.343
, pp. 1115-1122
-
-
-
53
-
-
0026787642
-
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
-
Swedberg K, Held P, Kjekshus J, Rasmussen K, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327:669-77.
-
(1992)
N Engl J Med
, vol.327
, pp. 669-677
-
-
Swedberg, K.1
Held, P.2
Kjekshus, J.3
Rasmussen, K.4
-
54
-
-
0031692258
-
Anti-ischaemic effects of ACE inhibitors: Review of current clinical evidence and ongoing clinical trials
-
Yusuf S, Lonn E. Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials. Eur Heart J 1998;19(Suppl J):J36-44.
-
(1998)
Eur Heart J
, vol.19
, Issue.SUPPL. J
-
-
Yusuf, S.1
Lonn, E.2
-
55
-
-
0027423378
-
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
-
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
-
(1993)
Lancet
, vol.342
, pp. 821-828
-
-
-
56
-
-
0026786643
-
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
-
Pfeffer MA, Braunwald E, Moye LA, Basta L, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327: 669-77.
-
(1992)
N Engl J Med
, vol.327
, pp. 669-677
-
-
Pfeffer, M.A.1
Braunwald, E.2
Moye, L.A.3
Basta, L.4
-
57
-
-
9044239676
-
A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
-
Kober L, Torppedersen C, Carlsen JE, Bagger H, et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333: 1670-6.
-
(1995)
N Engl J Med
, vol.333
, pp. 1670-1676
-
-
Kober, L.1
Torppedersen, C.2
Carlsen, J.E.3
Bagger, H.4
-
58
-
-
0030995759
-
Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study
-
Hall AS, Murray GD, Ball SG, on behalf of the AIREX Study Investigators. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Lancet 1997; 349:1493-7.
-
(1997)
Lancet
, vol.349
, pp. 1493-1497
-
-
Hall, A.S.1
Murray, G.D.2
Ball, S.G.3
-
59
-
-
0024312703
-
Strategies to manage the post-MI patient with ventricular arrhythmias
-
Weinberg B, Zipes D. Strategies to manage the post-MI patient with ventricular arrhythmias. Clin Cardiol 1989;12:86-90.
-
(1989)
Clin Cardiol
, vol.12
, pp. 86-90
-
-
Weinberg, B.1
Zipes, D.2
-
60
-
-
0001648677
-
Risk stratification and survival after myocardial infarction
-
The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:301-6.
-
(1983)
N Engl J Med
, vol.309
, pp. 301-306
-
-
-
61
-
-
0023694806
-
Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from the randomized controlled trials
-
MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized controlled trials. JAMA 1988;260:1910-6.
-
(1988)
JAMA
, vol.260
, pp. 1910-1916
-
-
MacMahon, S.1
Collins, R.2
Peto, R.3
Koster, R.W.4
Yusuf, S.5
-
62
-
-
0026011647
-
Mortality and morbidity in patients receiving encainide, flecainide or placebo: The Cardiac Arrhythmia Suppression trial. N
-
Echt DS, Liebson PR, Mitchell LB, Peters RW, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo: the Cardiac Arrhythmia Suppression trial. N Engl J Med 1991; 324:781-8.
-
(1991)
Engl J Med
, vol.324
, pp. 781-788
-
-
Echt, D.S.1
Liebson, P.R.2
Mitchell, L.B.3
Peters, R.W.4
-
63
-
-
0026752875
-
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
-
The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-33.
-
(1992)
N Engl J Med
, vol.327
, pp. 227-233
-
-
-
64
-
-
0031038213
-
Randomised trial of the effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
-
Julian DG, Camm AJ, Frangin G, Janse MJ, et al, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of the effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74.
-
(1997)
Lancet
, vol.349
, pp. 667-674
-
-
Julian, D.G.1
Camm, A.J.2
Frangin, G.3
Janse, M.J.4
-
65
-
-
0031029373
-
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
-
Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-82.
-
(1997)
Lancet
, vol.349
, pp. 675-682
-
-
Cairns, J.A.1
Connolly, S.J.2
Roberts, R.3
Gent, M.4
|